News

The upcoming report from Globus Medical (GMED) is expected to reveal quarterly earnings of $0.74 per share, indicating an increase of 2.8% compared to the year-ago period. Analysts forecast revenues ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. For millions of disabled people, essential health devices known as durable ...
ROME, N.Y. -- State Senator Joseph Griffo is addressing an audit that highlights concerns regarding medical equipment purchased by New York at the beginning of the COVID-19 pandemic. The audit was ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
Tren de Aragua, the Venezuelan migrant gang considered so dangerous by the US government that its members are now classified as terrorists, has been linked to a horrific case where a Washington ...
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...
Medical equipment procurement was spearheaded by then-Gov. Andrew Cuomo’s office during the early days of the pandemic, foregoing routine consultation with the Department of Health.